Search research articles
Contact Us
Filters
Showing results (141-150 of 235) with videos related to
Page
of 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2019
Genome-wide CRISPR screen for Zika virus resistance in human neural cells
Yun Li, Julien Muffat, Attya Omer Javed, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability
Qingsong Liu, Jinhua Wang, Seong A Kang, et al.
Cancer Cell
|
February 3, 2009
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice
David A Guertin, Deanna M Stevens, Maki Saitoh, et al.
The Journal of Biological Chemistry
|
January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Aging
|
August 10, 2013
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
Lan Ye, Anne L Widlund, Carrie A Sims, et al.
Cell
|
March 15, 2016
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Lynne Chantranupong, Sonia M Scaria, Robert A Saxton, et al.
Nature
|
July 13, 2022
Structure of the nutrient-sensing hub GATOR2
Max L Valenstein, Kacper B Rogala, Pranav V Lalgudi, et al.
Cell Reports
|
September 30, 2014
The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1
Lynne Chantranupong, Rachel L Wolfson, Jose M Orozco, et al.
Science (New York, N.Y.)
|
April 28, 2018
NUFIP1 is a ribosome receptor for starvation-induced ribophagy
Gregory A Wyant, Monther Abu-Remaileh, Evgeni M Frenkel, et al.
Journal of Medicinal Chemistry
|
September 24, 2010
Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer
Qingsong Liu, Jae Won Chang, Jinhua Wang, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 235) with videos related to
Sort By:
Page
of 24
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2019
Genome-wide CRISPR screen for Zika virus resistance in human neural cells
Yun Li, Julien Muffat, Attya Omer Javed, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability
Qingsong Liu, Jinhua Wang, Seong A Kang, et al.
Cancer Cell
|
February 3, 2009
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice
David A Guertin, Deanna M Stevens, Maki Saitoh, et al.
The Journal of Biological Chemistry
|
January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Aging
|
August 10, 2013
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
Lan Ye, Anne L Widlund, Carrie A Sims, et al.
Cell
|
March 15, 2016
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Lynne Chantranupong, Sonia M Scaria, Robert A Saxton, et al.
Nature
|
July 13, 2022
Structure of the nutrient-sensing hub GATOR2
Max L Valenstein, Kacper B Rogala, Pranav V Lalgudi, et al.
Cell Reports
|
September 30, 2014
The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1
Lynne Chantranupong, Rachel L Wolfson, Jose M Orozco, et al.
Science (New York, N.Y.)
|
April 28, 2018
NUFIP1 is a ribosome receptor for starvation-induced ribophagy
Gregory A Wyant, Monther Abu-Remaileh, Evgeni M Frenkel, et al.
Journal of Medicinal Chemistry
|
September 24, 2010
Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer
Qingsong Liu, Jae Won Chang, Jinhua Wang, et al.
Page
of 24